PMID: 9531148Apr 8, 1998Paper

Endoscopic management of urolithiasis in the morbidly obese patient

Journal of Endourology
T A Nguyen, J A Belis

Abstract

A retrospective review of 48 consecutive morbidly obese patients with urolithiasis who were treated successfully by endoscopic modalities over 3.5 years was performed. Of the 73 endoscopic procedures, 48 were ureteroscopic laser lithotripsy (UL), 4 were ureteroscopic basket extraction, and 21 were percutaneous nephrolithotripsy (PCNL). The patients' weight ranged from 205 to 385 lbs. (average 286 lbs.). Their abdominal girth ranged from 53 to 65 inches (average 59 inches). Twenty-six patients had one procedure, eight patients had bilateral procedures, eleven patients had two procedures, and three patients had three procedures with utilization of either multiple ureteroscopic treatments or the combination of percutaneous and ureteroscopic techniques. The stone-free rate after one procedure was 77.8% for UL and 60% for PCNL. The stone-free rate after planned repeat procedures was 97% for UL/UL and 89% for PCNL/UL. There were two minor complications. Forty-eight procedures were performed on an outpatient basis, and the remaining 25 procedures necessitated hospital admission (average 3.6 days). Morbidly obese patients with urolithiasis who are unable to have SWL because of their body weight and abdominal girth can be treated succes...Continue Reading

References

Sep 1, 1992·The Journal of Urology·R Hofmann, M L Stoller
Feb 1, 1988·The Journal of Urology·C C CarsonJ L Weinerth
Jan 1, 1996·The Journal of Urology·M ErhardD H Bagley
Jan 1, 1997·The Journal of Urology·W J HarmonJ W Segura

❮ Previous
Next ❯

Citations

Dec 7, 2007·Nature Clinical Practice. Urology·Aleksandra Vujovic, Stephen Keoghane
Apr 10, 2004·Journal of Endourology·Ari D SilversteinGlenn M Preminger
Mar 3, 2010·Journal of Endourology·Jeffrey J TomaszewskiTimothy D Averch
Jul 22, 2011·Journal of Endourology·Michael OrdonR John D'A Honey
Jun 22, 2007·Surgical Laparoscopy, Endoscopy & Percutaneous Techniques·Igor SergeyevDavid M Hoenig
Aug 27, 2011·Therapeutic Advances in Urology·Soroush Rais-BahramiArthur D Smith
Apr 13, 2011·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·B OliviL Guy
Nov 27, 2008·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·O TraxerC Saussine
Dec 13, 2006·European Urology·Ahmed M El-AssmyHamdy A El-Kappany
Aug 7, 2007·The Urologic Clinics of North America·J Stuart Wolf
Jun 9, 2004·Urology·Ronald M Yang, Gary C Bellman
May 8, 2000·The Journal of Urology·B K HollenbeckG J Faerber
Mar 26, 2004·The Urologic Clinics of North America·Manoj Monga, William W Beeman
Jun 26, 2014·World Journal of Urology·Guido GiustiPierpaolo Graziotti
Aug 10, 2016·SpringerPlus·Fatih AkbulutGokhan Gurbuz
Mar 24, 2016·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·N MoosanejadM Fazli
Mar 4, 2009·International Braz J Urol : Official Journal of the Brazilian Society of Urology·Ricardo NatalinMantu Gupta
Aug 7, 2007·The Urologic Clinics of North America·C Charles Wen, Stephen Y Nakada
Feb 24, 2005·Current Opinion in Urology·Robert C Calvert, Neil A Burgess
Aug 13, 2013·Postgraduate Medicine·Katrina F ChuPamela Ellsworth

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.